No increased risk of relapse after meningococcal C conjugate vaccine in nephrotic syndrome
AUTOR(ES)
Taylor, Brent
FONTE
BMJ Group
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2083230Documentos Relacionados
- Adrenocortical suppression increases the risk of relapse in nephrotic syndrome
- Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
- Immune Response to Meningococcal Serogroup C Conjugate Vaccine in Asplenic Individuals
- Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults.
- Validation of Serological Correlate of Protection for Meningococcal C Conjugate Vaccine by Using Efficacy Estimates from Postlicensure Surveillance in England